SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about clarification

27 Feb 2024 Evaluate
Alkem Laboratories has informed that the Company is in compliance with the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (Listing Regulations) and has been promptly intimating the Stock Exchanges regarding all events/ information which may have a bearing on the operation/ performance of the Company. There is no undisclosed price sensitive information which needs to be informed to the exchange at this point of time. Further, informed that Company will, as required under the Listing Regulations continue to promptly intimate the stock exchanges of all material events / information / actions. 

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5567.70 -8.65 (-0.16%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×